// App-Quantinova.ai

EP738 : T CELL LINEAGE MIXED CHIMERISM IN ACUTE LEUKAEMIA/MDS- IS IT PROGNOSTIC - A SINGLE CENTRE RETROSPECTIVE STUDY

Researchers

Presenter

  • Vipul Sheth

Principal Investigators

  • Victoria Potter

  • Hugues Delavallade

  • Shreyans Gandhi

  • Austin Kulasekararaj

  • Pramila Krishnamurthy

  • Varun Mehra

  • Francesco Dazzi

  • Ghulam Mufti

  • Antonio Pagliuca

  • Donal Mclornan

  • Kavita Raj

Medical Centers

  • Kings College hospital,London,United Kingdom

  • King's College, and King's College Hospital, London, United Kingdom

  • Gu-s and St Thoma- NHS, London, United Kingdom

  • Kings College London, London, United Kingdom

  • Fred Hutchinson Cancer Research Center, Seattle, WA, United States

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Alpha-thalassemia myelodysplasia syndrome

  • Acute Leukemia

Biomarkers

  • Cluster of Differentiation 2AP

  • Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon

Drug/Treatment

  • Alemtuzumab

Outcome

  • N/A


Study Design

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A